AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsiveness

Technology Benefits

Treatment of AHR

Technology Application

Treatment of AHR

Detailed Technology Description

Administration of CGRP to sensitized and challenged mice resulted in the normalization of AHR.This potential therapy for AHR was tested in phase II of clinical trials however the trial was never completed.

Supplementary Information

Inventor: Cadieux, Alain
Priority Number: US6743429B2
IPC Current: A61K003823
US Class: 4241981 | 5140119 | 514826 | 514012
Assignee Applicant: Sherbrooke University,Quebec
Title: Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
Usefulness: Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
Summary: CGRP and its natural homolog (their fragments, analogs or derivatives) are useful for the prevention or alleviation of asthma, bronchospastic disease characterized by airway hyperreactivity or lung inflammatory reaction characterized by increased eosinophilia (claimed).
Novelty: Use of calcitonin gene-related peptide for preventing, reducing and/or alleviating bronchospastic airway diseases, especially reversible airway hyperreactivity and lung inflammation encountered in asthma

Industry

Biomedical

Sub Group

Medical Composition

Country/Region

USA

For more information, please click Here